Biodel , Nasdaq: BIOD
Developing new treatments for diabetes and osteoporosis.
Industry: Health Care
First Day Return: +20.0%
Industry: Health Care
| IPO Data | |
|---|---|
| IPO File Date | 02/07/2007 |
| Offer Price | $15.00 |
| Price Range $14.00 - $16.00 | |
| Offer Shares (mm) | 5.0 |
| Deal Size ($mm) | $75 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 05/10/2007 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $75 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Danbury, CT, United States |
| Founded | 1991 |
| Employees at IPO | n/a |
| Website www.biodel.com | |
Biodel (BIOD) Performance
